Peer-reviewed veterinary case report
Neutrophil traps found in blood of dogs with immune anemia
By Lawson, C et al.·Published in Journal of veterinary internal medicine·2018·Department of Veterinary Clinical Sciences, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Neutrophil Extracellular Traps in Plasma from Dogs with Immune-mediated Hemolytic Anemia.
- Species:
- dog
Plain-English summary
A group of dogs with immune-mediated hemolytic anemia (IMHA), a serious condition where the immune system attacks red blood cells, showed signs of inflammation in their blood. Researchers found that a significant number of these dogs had elevated levels of certain markers associated with neutrophil extracellular traps (NETs), which are linked to inflammation and can cause further health issues. While some tests indicated the presence of NETs in these dogs, the findings suggest that excessive NETs may play a role in the complications of IMHA. This highlights the need for more research into how these markers affect treatment and outcomes for dogs with this condition.
People also search for: dog immune-mediated hemolytic anemia symptoms · IMHA treatment for dogs · neutrophil extracellular traps in dogs
Abstract
BACKGROUND: Neutrophil extracellular traps (NETs) are part of the innate immune response and are essential in local pathogen control, but are associated with pathological inflammation, organ damage, autoimmunity, and thrombosis. Immune-mediated hemolytic anemia (IMHA) is a pro-inflammatory, prothrombotic disease associated with high mortality. HYPOTHESIS/OBJECTIVES: Neutrophil extracellular traps (NETs) are a feature of the inflammatory process in dogs with IMHA. The objective of the study was to evaluate plasma from dogs with IMHA for the presence of 2 indirect markers and 1 direct marker of NETs. ANIMALS: Healthy client-owned dogs (56) and hospitalized dogs with IMHA (n = 35). METHODS: Prospective study. Plasma samples for all dogs were evaluated for cell-free DNA using a fluorescence assay, histone-DNA (hisDNA) complex using an ELISA, and citrullinated histone H3 (specific for NETosis) using Western blot. Reference intervals were generated using plasma from healthy dogs. RESULTS: In dogs with IMHA, cell-free DNA concentration was above the reference interval in 17% of samples with a median (range) of 1.0 μg/mL (0.1-17.3), and hisDNA concentration was above the reference interval in 94% of samples with a median (range) of 30.7 × pooled normal plasma (PNP; 0.6-372.1). Western blot for citrullinated histone H3 identified detectable bands in 84% samples from dogs with IMHA. CONCLUSIONS AND CLINICAL IMPORTANCE: The assay for cell-free DNA detected evidence of NETs in fewer dogs than did the other approaches. Excessive NETs appears to be a feature of IMHA in dogs and contributions to the prothrombotic state deserve further study.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/29214674/